These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 12529970)
1. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells. Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970 [TBL] [Abstract][Full Text] [Related]
2. Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells. Yamaguchi Y; Ohta K; Kawabuchi Y; Ohshita A; Okita R; Okawaki M; Hironaka K; Matsuura K; Toge T Anticancer Res; 2005; 25(3c):2407-15. PubMed ID: 16080467 [TBL] [Abstract][Full Text] [Related]
3. Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients. Hao X; Shao Y; Ren X; Liu H; Xu Q; Li H; Zhang P; An X; Ren B J Cancer Res Clin Oncol; 2002 Sep; 128(9):507-15. PubMed ID: 12242516 [TBL] [Abstract][Full Text] [Related]
4. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
5. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients. Ohshita A; Yamaguchi Y; Minami K; Okita R; Toge T Int J Oncol; 2006 May; 28(5):1163-71. PubMed ID: 16596232 [TBL] [Abstract][Full Text] [Related]
6. Host-oriented peptide evaluation using whole blood assay for generating antigen-specific cytotoxic T lymphocytes. Kawabuchi Y; Yamaguchi Y; Ohshita A; Minami K; Toge T Anticancer Res; 2004; 24(2C):1193-200. PubMed ID: 15154646 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Itoh T; Ueda Y; Kawashima I; Nukaya I; Fujiwara H; Fuji N; Yamashita T; Yoshimura T; Okugawa K; Iwasaki T; Ideno M; Takesako K; Mitsuhashi M; Orita K; Yamagishi H Cancer Immunol Immunother; 2002 Apr; 51(2):99-106. PubMed ID: 11904734 [TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2. Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824 [TBL] [Abstract][Full Text] [Related]
9. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Morse MA; Deng Y; Coleman D; Hull S; Kitrell-Fisher E; Nair S; Schlom J; Ryback ME; Lyerly HK Clin Cancer Res; 1999 Jun; 5(6):1331-8. PubMed ID: 10389916 [TBL] [Abstract][Full Text] [Related]
10. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen. Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612 [TBL] [Abstract][Full Text] [Related]
11. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells. Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells. Matsuda K; Tsunoda T; Tanaka H; Umano Y; Tanimura H; Nukaya I; Takesako K; Yamaue H Cancer Immunol Immunother; 2004 Jul; 53(7):609-16. PubMed ID: 14735319 [TBL] [Abstract][Full Text] [Related]
13. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769 [TBL] [Abstract][Full Text] [Related]
14. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen]. He B; Qiu G; Xie X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345 [TBL] [Abstract][Full Text] [Related]
15. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2. Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829 [TBL] [Abstract][Full Text] [Related]
17. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity. Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590 [TBL] [Abstract][Full Text] [Related]
18. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells. Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422 [TBL] [Abstract][Full Text] [Related]
19. Analysis of T cell receptors reactive with squamous cell carcinoma antigen SART-1 presented by the HLA-A24 molecule. Shimizu K; Yamaguchi Y; Ohta K; Miyahara E; Toge T Oncol Rep; 2002; 9(3):599-605. PubMed ID: 11956635 [TBL] [Abstract][Full Text] [Related]